korrents
Jacob Trefethen

What Jacob Trefethen thinks about epidemiology

@jacob-trefethen · 14 positions · On ppll ↗

Head of global health R&D at Open Philanthropy, where he directs funding for vaccines, drugs and diagnostics aimed at diseases that get little commercial attention. He writes at blog.jacobtrefethen.com and co-hosts the Hard Drugs podcast with Saloni Dattani.

Jacob Trefethen did not write this page.

We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording. Their own site. Is this you? Claim it or ask us to remove it. Or tell us what is wrong here.

Filter epidemiology · Newest first
Topic
All 14AI and science 4innovation 4epidemiology 2behavioural science 1capitalism 1dementia 1design 1
Sort
NewestOldest

Only Jacob Trefethen on epidemiology. See everyone on epidemiology

2 dated positions, 2025, in their own words. Our reading of what Jacob Trefethen has said — not written or endorsed by them.

2 positions so far — this page is not yet offered to search engines.

  1. Our readingSome diseases are technologically solved and still spread, because the remaining bottleneck is trust rather than science.

    Their wordsMeasles is technologically “solved”, but not everyone trusts the solutions or their messengers.

    ↗AI will not suddenly lead to an Alzheimer's cureblog.jacobtrefethen.com 5th of 5 in this piece

  2. 2 months earlier

  3. Our readingInfectious diseases get far less industry R&D per death than non-communicable ones, because they mostly kill people in countries where a cure pays less.

    Their wordsInfectious diseases as a category receive vastly less R&D spending from industry than non-communicable diseases, per death they cause, because they disproportionately kill people in lower- and middle-income countries where the payoff for making a cure is less lucrative.

    ↗A Quantitative Approach to Vaccine Fundingblog.jacobtrefethen.com 2nd of 2 in this piece